Variant report
Variant | nsv967028 |
---|---|
Chromosome Location | chr3:75930956-75937386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538101680 | chr3:75932600-75932601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs117014588 | chr3:75932601-75932602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571307660 | chr3:75932614-75932615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376835102 | chr3:75932651-75932652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547646037 | chr3:75932688-75932689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538632546 | chr3:75932692-75932693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111900936 | chr3:75932698-75932699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572151375 | chr3:75932760-75932761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540494438 | chr3:75932763-75932764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545885980 | chr3:75932784-75932785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377650054 | chr3:75932825-75932826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573522717 | chr3:75932829-75932830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574262777 | chr3:75932839-75932840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544843955 | chr3:75932895-75932896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563038493 | chr3:75932896-75932897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533187807 | chr3:75932938-75932939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181314936 | chr3:75932989-75932990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370892695 | chr3:75933009-75933010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147136348 | chr3:75933014-75933015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13078223 | chr3:75933043-75933044 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs567405807 | chr3:75933048-75933049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141038666 | chr3:75933055-75933056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550086968 | chr3:75933062-75933063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186321665 | chr3:75933069-75933070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141561209 | chr3:75933151-75933152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547390253 | chr3:75933152-75933153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368819877 | chr3:75933154-75933155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150879611 | chr3:75933226-75933227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139338706 | chr3:75933229-75933230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs190690787 | chr3:75933255-75933256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150033913 | chr3:75933269-75933270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545976498 | chr3:75933321-75933322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564474507 | chr3:75933338-75933339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182865892 | chr3:75933351-75933352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13078579 | chr3:75933419-75933420 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs75638308 | chr3:75933434-75933435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186414726 | chr3:75933447-75933448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375092918 | chr3:75933491-75933492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545016477 | chr3:75933524-75933525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560074652 | chr3:75933538-75933539 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572208154 | chr3:75933540-75933541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575072686 | chr3:75933590-75933591 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543152949 | chr3:75933688-75933689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561212598 | chr3:75933695-75933696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190967957 | chr3:75933805-75933806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534423429 | chr3:75933820-75933821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565201790 | chr3:75933895-75933896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532415970 | chr3:75933915-75933916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547426952 | chr3:75933923-75933924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146591447 | chr3:75933925-75933926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:75932600-75933800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr3:75932800-75933400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr3:75933400-75936200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
4 | chr3:75933800-75940400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr3:75936200-75936400 | Enhancers | HUES64 Cell Line | embryonic stem cell |